Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say

Travere Therapeutics and Vera Therapeutics are also developing treatments for rare kidney disease
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.